HIV Patients Illness Perception and Adherence
|ClinicalTrials.gov Identifier: NCT02276287|
Recruitment Status : Completed
First Posted : October 28, 2014
Last Update Posted : October 28, 2014
Background: the study aimed to explore HIV positive patients' perceptions toward illness and treatment, and their associations with demographic and clinical variables, in particular with adherence.
Methods: the study was conducted at the outpatients clinic of Infectious Disease of a University Hospital in the north of Italy. Patients were asked to fill out the Illness Perception Questionnaire-Revised. Patient's adherence was measured by: viral load (HIV-RNA copies/ml) and presence at the check up.
|Condition or disease|
|Study Type :||Observational|
|Actual Enrollment :||187 participants|
|Official Title:||HIV Positive Patient's Cognitive and Emotional Illness Perception: a Possible Tool for Understanding Adherence?|
|Study Start Date :||March 2013|
|Actual Primary Completion Date :||April 2014|
|Actual Study Completion Date :||April 2014|
- Illness representations [ Time Frame: participants will be followed for the duration of their hospital access, an expected average of 2 hours ]Illness Perception Questionnaire Revised (IPQ-R)
- demographic data [ Time Frame: participants will be followed for the duration of their hospital access, an expected average of 2 hours ]age, gender, marital status, education, employment status, nationality
- clinical data [ Time Frame: from date of HIV diagnosis until the date of the visit in which patients were recruited for the study , assessed from 1984 to 2014 ]years diagnosed with HIV, patient history of antiretroviral therapy, years of therapy (first therapy and current therapy), presence of fix dose combination of antiretroviral drugs, current therapeutic regimen's type (once a day and twice a day), total number of pills per day, presence of other drugs' therapies, HIV acquisition risk.
- Adherence [ Time Frame: Adherence indexes assessed at the last check up visit (from 2 weeks up to 12 months) ]HIV-RNA copies/ml, and presence at the check up visits
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02276287
|Study Director:||Elena Vegni, Professor||University of Milan|